Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

A big acquisition juiced the hospital operator's stock.

Why Tenet Healthcare Skyrocketed on Thursday

Greenwich Lifesciences

Immutep Ltd

Immutep (NASDAQ: IMMP) shares are trading higher on Thursday after the company reported a statistically significant survival benefit for key patient groups in its ongoing Phase IIb AIPAC study in metastatic breast cancer. Immutep is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases.

Why Greenwich LifeSciences, Immutep And Tenet Are Trading Higher Today

Tenet Healthcare Corp. said Thursday it has agreed to acquire a portfolio of up to 45 ambulatory surgery centers from SurgCenter Development for $1.1 billion in cash, plus the assumption of $18 million of debt. The centers will be operated by Tenet's United Surgical Partners International unit, which will own up to 60% of each center.

Tenet Healthcare to acquire portfolio of 45 ambulatory surgery centers for $1.1 billion in cash

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced that it will acquire a portfolio of up to 45 ambulatory surgery centers (ASCs) (the “Portfolio”) from SurgCenter Development (SCD). The Portfolio will be operated by Tenet's United Surgical Partners International (USPI) subsidiary as part of its industry-leading ambulatory surgery platform. SCD, founded in 1993, is a leading developer of physician-owned ASCs with a history of establishing high-quality centers in p

Tenet to Acquire Portfolio of Surgery Centers from SurgCenter Development

Is Tenet Healthcare (THC) a great pick from the value investor's perspective right now? Read on to know more.

Is Tenet Healthcare (THC) a Profitable Stock to Pick Now?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of J. Roger Davis as President and Chief Executive Officer of its Conifer Health Solutions subsidiary, effective immediately. Davis has over 30 years of experience in healthcare services and a deep background in revenue cycle operations for hospitals and physician practices. His skillset spans different dimensions of healthcare including strategic planning, execution and commercial growth, as well

Tenet Announces Roger Davis as President and CEO of Conifer

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2020 Leveraged Finance Virtual Conference on Tuesday, December 1, 2020 beginning at 9:45 a.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The audio archive will be available on Tenet's website for approximately 30 days. About Tenet Healthcare Tenet Healthcare Co

Tenet to Participate in BofA Securities 2020 Leveraged Finance Virtual Conference

Tenet (THC) reported earnings 30 days ago. What's next for the stock?

Why Is Tenet (THC) Up 11.8% Since Last Earnings Report?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will participate in the following virtual investor conferences in November. The 29th Annual Credit Suisse Virtual Healthcare Conference on Wednesday, Nov. 11, 2020 at 10:15 a.m. Eastern time. The 2nd Annual Wolfe Research Healthcare Conference on Wednesday, Nov. 18 at 9:50 a.m. Eastern time. A live webcast and audio archive of each event may be accessed through the investor relations section of Tenet's website at www.tenethealth.

Tenet to Participate in Virtual Investor Conferences in November

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of Saum Sutaria, M.D., the Company's President and Chief Operating Officer, to its Board of Directors, effective immediately. This appointment expands the Board to include 11 directors. Ron Rittenmeyer, Executive Chairman and CEO, said, “Saum has led a remarkable effort across the enterprise to enhance care delivery and critical support services to benefit the many stakeholders we serve. His leader

Tenet Appoints Saum Sutaria to Board of Directors

Tenet Healthcare Corp's (THC) CEO Ron Rittenmeyer on Q3 2020 Results - Earnings Call Transcript

Tenet Healthcare's (THC) third-quarter earnings gain from the Ambulatory segment and lower expenses.

Tenet Healthcare's (THC) Earnings Beat in Q3, Improve Y/Y

Tenet (THC) delivered earnings and revenue surprises of 93.94% and 4.76%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Tenet Healthcare (THC) Tops Q3 Earnings and Revenue Estimates

Shares of Tenet Healthcare (NYSE:THC) fell 0.25% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 10.34% year over year to $0.64, which beat the estimate of $0.31.

Tenet Healthcare: Q3 Earnings Insights

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2020 (3Q20). Ronald A. Rittenmeyer, Executive Chairman and Chief Executive Officer, stated, “The third quarter of 2020 was in many ways more challenging than the second, with COVID positive inpatient census surging by approximately 64 percent in our markets in late July and August. Our operators executed exceptionally throughout our entire system, ensuring th

Tenet Reports Third Quarter 2020 Results and Provides Update on Effects of COVID-19

Riding high on its strategic measures and cost-cutting methods, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

Here's Why You Should Retain Tenet Healthcare (THC) Stock

Acadia Healthcare

HCA Healthcare

Universal Health Services

While the Zacks Medical-Hospital industry was at the receiving end of the coronavirus pandemic, which caused a decline in elective procedures and consequently, dried up the revenues, federal dollars came to the industry’s rescue to minimize its damages to a certain extent..

4 Hospital Stocks to Gain from Improving Admissions, Federal Aid

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) plans to report results for its third quarter ended September 30, 2020 after the market closes on Tuesday, October 20, 2020. The company will host a conference call the following morning, Wednesday, October 21, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. The audio archiv

Tenet to Report its Third Quarter Results on October 20

Universal Health (UHS) and Tenet Healthcare (THC) are poised to grow. On comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.

UHS or THC: Which is a Better-Positioned Stock Right Now?

A nearly 30% price target cut from a noted investment bank was the culprit.

Why Tenet Healthcare Dived 13% on Monday

Centene

Community Health Systems

Molina Healthcare

The death of justice Ruth Bader Ginsburg changes the dynamics of the upcoming Obamacare case at the high court.

Health-care stocks fall on uncertainty over Supreme Court and Obamacare

Tenet Healthcare: A Great Play In The Healthcare Space

Tenet Healthcare shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.
The post Stocks Showing Rising Market Leadership: Tenet Healthcare Earns 82 RS Rating appeared first on Investor's Business Daily.

Stocks Showing Rising Market Leadership: Tenet Healthcare Earns 82 RS Rating

FRISCO, Texas--(BUSINESS WIRE)--Conifer Health Solutions, LLC, a subsidiary of Tenet Healthcare Corporation (NYSE: THC), has announced the promotion of Mary Bacaj to president of its Conifer Value-Based Care, LLC business unit. Bacaj has served as a company vice president since 2015 and has led Value-Based Care since August 2019.

Conifer Health Names Mary Bacaj President of Value-Based Care

Riding high on divestitures and cost-reduction, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

News for Tenet Healthcare Stock (THC)